Matthias Kappler

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. doi request reprint Predictive values of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis one year after early eradication treatment
    Matthias Kappler
    Children s University Hospital of the Ludwig Maximilians University of Munich, Lindwurmstr 4, 80337 Munich, Germany Electronic address
    J Cyst Fibros 13:534-41. 2014
  2. doi request reprint Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study
    M Kappler
    Children s University Hospital of the Ludwig Maximilians University, Dr von Haunersches Kinderspital, Munich, Germany
    Aliment Pharmacol Ther 36:266-73. 2012
  3. pmc Categorizing diffuse parenchymal lung disease in children
    Matthias Griese
    Department of Pediatric Pneumology, Dr von Haunersches Kinderspital, University of Munich, German Center for Lung Research, Lindwurmstraße 4, 80337, Munich, Germany
    Orphanet J Rare Dis 10:122. 2015
  4. pmc The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort
    Carolin Kröner
    Pediatric Pneumology and Christiane Herzog Cystic Fibrosis Center, Dr, von Hauner Children s Hospital, Ludwig Maximilians University, Lindwurmstr, 4, 80337 Munich, Germany
    BMC Pulm Med 13:61. 2013
  5. doi request reprint Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial
    Matthias Griese
    Children s Hospital, Ludwig Maximilians University, Munich, Germany
    Am J Respir Crit Care Med 188:83-9. 2013
  6. doi request reprint Surfactant proteins in pediatric interstitial lung disease
    Matthias Griese
    Dr von Hauner Children s Hospital, German Center for Lung Research DZL, University of Munich, Munich, Germany
    Pediatr Res 79:34-41. 2016
  7. pmc Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome
    Matthias Griese
    Dr von Haunersches Kinderspital, University of Munich, Munich, Germany
    PLoS ONE 7:e51050. 2012
  8. pmc In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients
    Andreas Hector
    Pediatric Pulmonology, Children s Hospital, University of Munich, 80337 Munich, Germany
    Mediators Inflamm 2010:809591. 2010
  9. doi request reprint Endobronchial lesions caused by nontuberculous mycobacteria in apparently healthy pediatric patients
    Carolin Kröner
    From the Department of Pediatrics, Dr von Hauner Children s Hospital, Ludwig Maximilians University, Munich, Germany
    Pediatr Infect Dis J 34:532-5. 2015
  10. pmc GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders
    Matthias Griese
    Hauner Children s University Hospital, Ludwig Maximilians University, Member of the German Center for Lung Research, Lindwurmstr 4, 80337, Munich, Germany
    BMC Pulm Med 15:87. 2015

Detail Information

Publications11

  1. doi request reprint Predictive values of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis one year after early eradication treatment
    Matthias Kappler
    Children s University Hospital of the Ludwig Maximilians University of Munich, Lindwurmstr 4, 80337 Munich, Germany Electronic address
    J Cyst Fibros 13:534-41. 2014
    ..For this purpose we assessed serum antibodies against P. aeruginosa in CF patients after early eradication treatment...
  2. doi request reprint Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study
    M Kappler
    Children s University Hospital of the Ludwig Maximilians University, Dr von Haunersches Kinderspital, Munich, Germany
    Aliment Pharmacol Ther 36:266-73. 2012
    ..The prevention and treatment of liver disease associated with cystic fibrosis remain a significant unresolved problem...
  3. pmc Categorizing diffuse parenchymal lung disease in children
    Matthias Griese
    Department of Pediatric Pneumology, Dr von Haunersches Kinderspital, University of Munich, German Center for Lung Research, Lindwurmstraße 4, 80337, Munich, Germany
    Orphanet J Rare Dis 10:122. 2015
    ..Aim of this study was to verify a systematic and practical categorization system that allows dynamic classification of pediatric DPLD irrespective of completeness of patient data...
  4. pmc The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort
    Carolin Kröner
    Pediatric Pneumology and Christiane Herzog Cystic Fibrosis Center, Dr, von Hauner Children s Hospital, Ludwig Maximilians University, Lindwurmstr, 4, 80337 Munich, Germany
    BMC Pulm Med 13:61. 2013
    ..The relevance of Trichosporon species for cystic fibrosis (CF) patients has not yet been extensively investigated...
  5. doi request reprint Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial
    Matthias Griese
    Children s Hospital, Ludwig Maximilians University, Munich, Germany
    Am J Respir Crit Care Med 188:83-9. 2013
    ..Glutathione is the major antioxidant in the extracellular lining fluid of the lungs and depleted in patients with cystic fibrosis (CF)...
  6. doi request reprint Surfactant proteins in pediatric interstitial lung disease
    Matthias Griese
    Dr von Hauner Children s Hospital, German Center for Lung Research DZL, University of Munich, Munich, Germany
    Pediatr Res 79:34-41. 2016
    ..Therefore, our objective was to determine the value of quantitation of SP-B and SP-C levels in bronchoalveolar lavage fluid (BALF) for the diagnosis of chILD...
  7. pmc Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome
    Matthias Griese
    Dr von Haunersches Kinderspital, University of Munich, Munich, Germany
    PLoS ONE 7:e51050. 2012
    ..In this study we focus on SP-A structure in cystic fibrosis (CF) compared to both healthy subjects and disease controls...
  8. pmc In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients
    Andreas Hector
    Pediatric Pulmonology, Children s Hospital, University of Munich, 80337 Munich, Germany
    Mediators Inflamm 2010:809591. 2010
    ..A previous study suggested neutrophil elastase activation by colistin in vitro. Here, we investigated direct effects of the commonly used antibiotics colistin and tobramycin on neutrophil elastase activity...
  9. doi request reprint Endobronchial lesions caused by nontuberculous mycobacteria in apparently healthy pediatric patients
    Carolin Kröner
    From the Department of Pediatrics, Dr von Hauner Children s Hospital, Ludwig Maximilians University, Munich, Germany
    Pediatr Infect Dis J 34:532-5. 2015
    ..Bronchoscopic debulking was performed in all patients and tuberculostatic treatment in 4. All patients including 1 without tuberculostatic treatment showed remission. ..
  10. pmc GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders
    Matthias Griese
    Hauner Children s University Hospital, Ludwig Maximilians University, Member of the German Center for Lung Research, Lindwurmstr 4, 80337, Munich, Germany
    BMC Pulm Med 15:87. 2015
    ..A multitude of genetic and exogenous causes are responsible for few other cases. Goal of this study was to determine the prevalence of GATA2 deficiency in children and adults with PAP and hematologic disorders...
  11. doi request reprint Long-term pulmonary outcome after meconium ileus in cystic fibrosis
    Matthias Kappler
    Children s University Hospital of the Ludwig Maximilians University, Munich, Germany
    Pediatr Pulmonol 44:1201-6. 2009
    ..To identify cystic fibrosis (CF) patients with a history of meconium ileus (MI) and to compare long-term outcome of these patients with CF patients without MI...